CVB logo

CurveBeam AI Limited Stock Price

ASX:CVB Community·AU$35.6m Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author

CVB Share Price Performance

AU$0.09
-0.05 (-33.33%)
40.0% undervalued intrinsic discount
AU$0.15
Fair Value
AU$0.09
-0.05 (-33.33%)
40.0% undervalued intrinsic discount
AU$0.15
Fair Value
Price AU$0.09
AnalystConsensusTarget AU$0.15

CVB Community Narratives

AnalystConsensusTarget·
Fair Value AU$0.15 40.0% undervalued intrinsic discount

FDA Clearance And AI Advances Will Unlock Future Markets

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative

Recent CVB News & Updates

Does CurveBeam AI (ASX:CVB) Have A Healthy Balance Sheet?

Aug 29
Does CurveBeam AI (ASX:CVB) Have A Healthy Balance Sheet?
User avatar

HiRise Orders And Australasian Expansion Will Fuel Market Success

Strong HiRise demand, expanded agreements, and protocol validation are set to drive revenue and sales growth, boosting future earnings.

CurveBeam AI (ASX:CVB) Is Making Moderate Use Of Debt

Mar 11
CurveBeam AI (ASX:CVB) Is Making Moderate Use Of Debt

CurveBeam AI Limited Key Details

AU$12.1m

Revenue

AU$6.7m

Cost of Revenue

AU$5.4m

Gross Profit

AU$22.3m

Other Expenses

-AU$16.8m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.043
Gross Margin
44.89%
Net Profit Margin
-139.24%
Debt/Equity Ratio
45.5%

CurveBeam AI Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Undervalued with high growth potential.

2 Risks
3 Rewards

About CVB

Founded
2009
Employees
n/a
CEO
Gregory Brown
WebsiteView website
curvebeamai.com

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and Australia. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools. It also provides software CurveBeam AI Autometrics for automatically segment foot and ankle datasets; Axiometrics, provides a semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle; and TALAS, a measurement tool that semi-automatically calculate hindfoot alignment based on reproducible three-dimensional anatomical landmarks. In addition, the company offers custom web-based cloud platform; and OSSView. The company was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 0.4%
  • 3 Months: 7.8%
  • 1 Year: 17.8%
  • Year to Date: 14.7%
In the last week, the market has stayed flat, however the Healthcare sector stood out, gaining 3.7%. As for the longer term, the market has risen 18% in the past 12 months. Looking forward, earnings are forecast to grow by 15% annually. Market details ›